Medicine and Dentistry
Mitogen-Activated Protein Kinase
100%
Protein Tyrosine Phosphatase SHP 2
50%
Diseases
33%
Germline Mutation
33%
Costello Syndrome
33%
Patient
33%
Inpatient
33%
Protein
16%
Cell Proliferation
16%
Facies
16%
Phenotype
16%
Programmed Cell Death
16%
Noonan Syndrome
16%
Neurofibromatosis Type I
16%
Congenital Malformation
16%
Sensorineural Hearing Loss
16%
Intellectual and Developmental Disabilities
16%
Autosomal Dominant Inheritance
16%
Human Development
16%
Mitogen Activated Protein Kinase Kinase 2
16%
Hypertelorism
16%
Pulmonary Valve Stenosis
16%
Lentigo
16%
Mitogen Activated Protein Kinase Kinase 1
16%
Gene
16%
Growth
16%
Differentiation
16%
Mutant
16%
Heart
16%
Survival
16%
Neuroscience
Mitogen-Activated Protein Kinase
83%
Protein Tyrosine Phosphatase SHP 2
50%
Costello Syndrome
33%
MAP2K1
33%
Cell Proliferation
16%
Extracellular Signal-Regulated Kinases
16%
Stenosis
16%
Phenotype
16%
Intellectual and Developmental Disabilities
16%
Neurofibromatosis
16%
Mitogen Activated Protein Kinase Kinase 1
16%
Mitogen Activated Protein Kinase Kinase 2
16%
MAP2K2
16%
Gene
16%
Protein
16%
Immunology and Microbiology
Mutation
100%
Molecule
33%
Germline Mutation
33%
Cell Proliferation
16%
Phenotype
16%
Cell Death
16%
Autosomal Dominant Inheritance
16%
Human Development
16%
Growth
16%
Gene
16%
Mutant
16%
Differentiation
16%
Survival
16%
Heart
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lentigo
16%
Hypertelorism
16%
Mitogen Activated Protein Kinase Kinase 2
16%
Biochemistry, Genetics and Molecular Biology